LeafNLP Demos
Back to explore

Report #2878371

Received Dec 17, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
SC
Recovered
Unknown
Vaccinated
Oct 27, 2025
Onset
Nov 21, 2025
Days to onset
25
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATION1——

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

Received the Second Dose of Heplisav-B Three Days Short of 1 Month; Initial report received on 21-Nov-2025. A pharmacist reported that a patient received the second dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization three days short of one month. No medical history or concomitant medications were reported. On 27-Oct-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, site, and route not provided)]. On 21-Nov-2025, the patient received dose 2 of a hepatitis B vaccine [HEPLISAV-B (lot number 946908, expiration date 21-Dec-2027, and NDC number 43528-0003-05; site not provided)] intramuscularly. This dose was received three days short of one month after the first dose. No side effects were reported. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.